Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT05441358Unknown

Assessment of Platelet Function in Patients Undergoing Open Heart Surgery

Role: collaborator

NCT03615846Unknown

Comparison of the VerifyNow® Aspirin Test and PRUTest® Platelet Reactivity Tests With Investigational Reagent to Reagents Registered in Japan

Role: lead

NCT02586818Withdrawn

Clinical Performance of Investigational InRhythm PT/INR System in a Professional Use Setting

Role: lead

NCT04492423Completed

VerifyNow® PRUTest® Cardiovascular Population Expected Values On-Drug Study

Role: lead

NCT03930875Completed

Aspirin Resistance in OSA Patients

Role: collaborator

NCT03074266Unknown

Clinical Performance of the Investigational GEM Hemochron® 100 in Populations Ages 18 Years and Older

Role: lead

All 6 trials loaded